Ideal Cures has three manufacturing plants located in Vasai, Jammu, and Khambat and two R&D facilities in Mumbai and Vasai. The coating and excipient provider also has another plant under construction in Sikkim.
Kamlesh Oza PhD, President, Global Business Development at Ideal Cures, told us, “with the advent of TA coming on board customers will be confident of a global, long-term, secure supply chain.”
With the investment, financial terms of which were not disclosed, Oza said Ideal Cures is building its business and teams.
Additionally, Oza said the company will leverage TA in order to expand its global business, “especially with multinational companies,” he added.
“Over the years, TA has developed relationships in the healthcare space who are or will be potential customers for Ideal Cures,” Oza explained. “Further, TA’s corporate development capabilities will provide the financial and operational expertise to help the company expand upon its solutions.”